(Q74623711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Tolterodine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C J Hills

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S A Winter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J A Balfour

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

813-20; discussion 821-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9617596%20AND%20SRC:MED&resulttype=core&format=json

Tolterodine--a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data

12 November 2019

cites work

1 reference

12 December 2020

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

1 reference

12 December 2020

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

12 December 2020

Current concepts in the treatment of disorders of micturition

1 reference

12 December 2020

Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity

1 reference

12 December 2020

Genuine stress incontinence and detrusor instability--a review of 200 patients.

1 reference

12 December 2020

Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

1 reference

12 December 2020

Dose-ranging study of tolterodine in patients with detrusor hyperreflexia

1 reference

12 December 2020

Tolterodine--a new bladder-selective antimuscarinic agent

1 reference

12 December 2020

Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine

1 reference

12 December 2020

Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity

1 reference

12 December 2020

Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine

1 reference

12 December 2020